InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Carotid Stent System; and SwitchGuard neuroprotection system to provide flow reversal of cerebral protection in carotid interventions, as well as treating acute stroke with tandem lesions. The company was founded in 2005 and is headquartered in Miami, Florida.
Frequently asked questions
What sector does InspireMD Inc (NSPR) operate in?
InspireMD Inc belongs to the Healthcare sector and operates in the Medical Devices industry.
What is InspireMD Inc (NSPR) current stock price?
As of the latest data, InspireMD Inc stock price is $0.44, with a previous close of $0.45. InspireMD Inc lost -$0.01 in the last trading session, representing a -2.44% loss.
What is InspireMD Inc (NSPR) current market capitalization?
InspireMD Inc market cap is approximately 20.56 million.
What is InspireMD Inc (NSPR) Earnings Per Share (EPS)?
The trailing EPS is -$0.61, and the forward EPS is -$0.48.
What is InspireMD Inc (NSPR) EBITDA?
InspireMD Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -14.17 million.
Does InspireMD Inc (NSPR) pay dividends?
No. InspireMD Inc does not pay a dividend.
How did InspireMD Inc (NSPR) perform in its most recent earnings report?
In the last report (June 30, 2026), InspireMD Inc posted an EPS surprise of 15% and a revenue surprise of 28.05%.
When is InspireMD Inc (NSPR) next earnings report?
InspireMD Inc is expected to release its next earnings report on September 30, 2026.
What is InspireMD Inc (NSPR) beta (volatility) score?
InspireMD Inc has a beta of 0.823, meaning its volatility is roughly in line with the market.
